WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009137677) REAGENTS, METHODS, AND SYSTEMS FOR DETECTING METHICILLIN-RESISTANT STAPHYLOCOCCUS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/137677    International Application No.:    PCT/US2009/043143
Publication Date: 12.11.2009 International Filing Date: 07.05.2009
IPC:
C07K 16/12 (2006.01), C12P 21/08 (2006.01)
Applicants: INNOVATIVE BIOSENSORS, INC. [US/US]; 15601 Crabbs Branch Way Rockville, Maryland 20855 (US) (For All Designated States Except US).
COTE, Colette [US/US]; (US) (For US Only).
ZHENG, Qiao-Xi [--/US]; (US) (For US Only).
SHYAMALA, Venkatakrishna [--/US]; (US) (For US Only).
HAZEL, Tom [US/US]; (US) (For US Only)
Inventors: COTE, Colette; (US).
ZHENG, Qiao-Xi; (US).
SHYAMALA, Venkatakrishna; (US).
HAZEL, Tom; (US)
Agent: HAYMAN, Mark; Cooley LLP 777 6th Street, NW Suite 1100 Washington, DC 20001 (US)
Priority Data:
61/126,831 07.05.2008 US
61/092,267 27.08.2008 US
Title (EN) REAGENTS, METHODS, AND SYSTEMS FOR DETECTING METHICILLIN-RESISTANT STAPHYLOCOCCUS
(FR) RÉACTIFS, PROCÉDÉS ET SYSTÈMES DE DÉTECTION DE STAPHYLOCOQUES RÉSISTANTS À LA MÉTHICILLINE (SARM)
Abstract: front page image
(EN)The present invention provides PBP2a peptide antigens for generating antibodies against MRSA, and provides high-affinity binding agents that detect MRSA by selective immunoreactivity with PBP2a. The antibodies are useful in methods and systems for detecting MRSA, including biosensor systems, or as components of diagnostic or detection kits. The antibodies, in some embodiments, have therapeutic value against MRSA infection.
(FR)La présente invention concerne des antigènes peptidiques PBP2a destinés à produire des anticorps anti-SARM et donnant des agents à haute affinité de liaison, capables de détecter des SARM par immunoréactivité sélective avec le PBP2a. Ces anticorps se révèlent utiles dans le cadre de procédés et de systèmes de détection de SARM, dont des systèmes impliquant des biodétecteurs ou, alors, en tant que composants de trousses de diagnostic ou de détection. Dans certains modes de réalisation, les anticorps présentent un intérêt thérapeutique contre l'infection par le SARM.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)